NICOLAS VERGARA: Open Payments
NPI 1003084625 · HOUMA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$889 in 36 payments from 7 companies in 2025. Trend: 2023 $616 · 2024 $837 · 2025 $889
Food & beverage: $889
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $370 |
| E.R. Squibb & Sons, L.L.C. | 11 | $278 |
| Lundbeck LLC | 5 | $99 |
| Teva Pharmaceuticals USA, Inc. | 2 | $59 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Alkermes, Inc. | 1 | $27 |
Products named: ABILIFY ASIMTUFII, COBENFY, ABILIFY MAINTENA, UZEDY, REXULTI, INGREZZA, SPRAVATO, ARISTADA.
Industry payments across LA — which companies pay providers there.
